RecruitingPhase 3NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sponsor: Bristol-Myers Squibb
Washington D.C., DC · +121 more sites
Psoriasis clinical trials in Washington D.C., DC
4 recruiting psoriasis studies with a site in Washington D.C., DC.
RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Washington D.C., DC · +50 more sites
RecruitingPhase 3NCT06100744
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Sponsor: AbbVie
Washington D.C., DC · +11 more sites
RecruitingPhase not listedNCT02418442
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Sponsor: Duke University
Washington D.C., DC · +74 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.